BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37327464)

  • 1. Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance Recommendations.
    Conduit C; Lewin J; Weickhardt A; Lynam J; Wong S; Grimison P; Sengupta S; Pranavan G; Parnis F; Bastick P; Campbell D; Hansen AR; Leonard M; McJannett M; Stockler MR; Gibbs P; Toner G; Davis ID; Tran B; Kuchel A
    JCO Oncol Pract; 2023 Nov; 19(11):973-980. PubMed ID: 37327464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance.
    Kollmannsberger C; Tandstad T; Bedard PL; Cohn-Cedermark G; Chung PW; Jewett MA; Powles T; Warde PR; Daneshmand S; Protheroe A; Tyldesley S; Black PC; Chi K; So AI; Moore MJ; Nichols CR
    J Clin Oncol; 2015 Jan; 33(1):51-7. PubMed ID: 25135991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.
    Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
    Diagn Pathol; 2013 Apr; 8():57. PubMed ID: 23566361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late relapse of testicular germ cell neoplasms: a descriptive analysis of 122 cases.
    Dieckmann KP; Albers P; Classen J; De Wit M; Pichlmeier U; Rick O; Müllerleile U; Kuczyk M
    J Urol; 2005 Mar; 173(3):824-9. PubMed ID: 15711278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
    Hosni A; Warde P; Jewett M; Bedard P; Hamilton R; Moore M; Nayan M; Huang R; Atenafu EG; O'Malley M; Sweet J; Chung P
    Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):648-54. PubMed ID: 27339401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance in stage I testicular seminoma - risk of late relapse.
    Chung P; Parker C; Panzarella T; Gospodarowicz MK; Jewett S; Milosevic MF; Catton CN; Bayley AJ; Tew-George B; Moore M; Sturgeon JF; Warde P
    Can J Urol; 2002 Oct; 9(5):1637-40. PubMed ID: 12431325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two cycles of adjuvant carboplatin for clinical stage 1 testicular seminoma in New Zealand centres: A retrospective analysis of efficacy and long-term events.
    Chandran EA; Chindewere A; North R; Jameson MB
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1310. PubMed ID: 33103860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance of stage I testicular seminoma: British Columbia Cancer Agency Experience 1992 to 2002.
    Tyldesley S; Voduc D; McKenzie M; Duncan G; Liu M; Wu D
    Urology; 2006 Mar; 67(3):594-8. PubMed ID: 16527585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
    Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
    Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
    Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late Relapses in Stage I Testicular Cancer Patients on Surveillance.
    Mortensen MS; Lauritsen J; Kier MG; Bandak M; Appelt AL; Agerbæk M; Holm NV; Kempel MM; von der Maase H; Daugaard G
    Eur Urol; 2016 Aug; 70(2):365-71. PubMed ID: 26996661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.
    Bilici A; Ozturk T; Turkmen E; Odabas H; Cihan S; Selcukbiricik F; Erdogan B; Urakci Z; Kandemir N; Bayoglu IV; Demirci U; Duran AO; Sendur MA; Yavuzer D; Harputluoglu H; Kavgaci H; Gumus M
    World J Urol; 2015 Oct; 33(10):1613-22. PubMed ID: 25605506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
    Oldenburg J; Aparicio J; Beyer J; Cohn-Cedermark G; Cullen M; Gilligan T; De Giorgi U; De Santis M; de Wit R; Fosså SD; Germà-Lluch JR; Gillessen S; Haugnes HS; Honecker F; Horwich A; Lorch A; Ondruš D; Rosti G; Stephenson AJ; Tandstad T
    Ann Oncol; 2015 May; 26(5):833-838. PubMed ID: 25378299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma.
    Fischer S; Tandstad T; Wheater M; Porfiri E; Fléchon A; Aparicio J; Klingbiel D; Skrbinc B; Basso U; Shamash J; Lorch A; Dieckmann KP; Cohn-Cedermark G; Ståhl O; Chau C; Arriola E; Marti K; Hutton P; Laguerre B; Maroto P; Beyer J; Gillessen S
    J Clin Oncol; 2017 Jan; 35(2):194-200. PubMed ID: 27893332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjuvant treatment for stage I of testicular germ cell tumours].
    Lakomý R; Poprach A; Nēmecek R; Vyskocil J; Ondrová B; Kocák I; Kocáková I; Rehák Z; Vyzula R
    Klin Onkol; 2009; 22(1):22-6. PubMed ID: 19534436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late results of surveillance of clinical stage I nonseminoma germ cell testicular tumours: 17 years' experience in a national study in New Zealand.
    Colls BM; Harvey VJ; Skelton L; Frampton CM; Thompson PI; Bennett M; Perez DJ; Dady PJ; Forgeson GV; Kennedy IC
    BJU Int; 1999 Jan; 83(1):76-82. PubMed ID: 10233456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New treatments for stage I testicular cancer.
    Nappi L; Nichols CR; Kollmannsberger CK
    Clin Adv Hematol Oncol; 2017 Aug; 15(8):626-631. PubMed ID: 28949950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nationwide cohort study of stage I seminoma patients followed on a surveillance program.
    Mortensen MS; Lauritsen J; Gundgaard MG; Agerbæk M; Holm NV; Christensen IJ; von der Maase H; Daugaard G
    Eur Urol; 2014 Dec; 66(6):1172-8. PubMed ID: 25064686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
    Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.